T Jovelin

Metabolic Syndrome in French HIV-Infected Patients: Prevalence and Predictive Factors After 3 Years of Antiretroviral Therapy

Antoine Biron, Christine Bobin‐Dubigeon, Christelle Volteau et al. · AIDS Research and Human Retroviruses · 2012 · 55 citations

Veterinary Medicine, Clinical Sciences, Clinical Nutrition +16

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination

Sidonie Lambert-Niclot, Clotilde Allavena, Maxime Grudé et al. · Journal of Antimicrobial Chemotherapy · 2016 · 23 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study

Marie Chauveau, Éric Billaud, B. Bonnet et al. · Journal of Antimicrobial Chemotherapy · 2018 · 15 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16

Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat’AIDS Cohort Study

Marie Demontès, Sabrina Eymard Duvernay, Clotilde Allavena et al. · Clinical Infectious Diseases · 2019 · 15 citations · Full text

Public Health, Geriatric Medicine, Epidemiology +16

Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting

Colin Deschanvres, Jacques Reynes, I. Lamaury et al. · Journal of Antimicrobial Chemotherapy · 2021 · 13 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +17